74

rezultat(e)

Cuvânt (cuvinte)
Tipul publicației
Domeniul tematic
Autor
Cuvânt-cheie
Data

Coronavirus vaccines strategy

29-09-2020

On 17 June 2020, the European Commission presented a strategy to accelerate the development, manufacturing and deployment of vaccines against the coronavirus disease (Covid-19). The strategy aims to secure high quality, safe, effective and affordable Covid-19 vaccines for all in the EU within 12-18 months, if not earlier. To this end, the Commission has started to enter into advance purchase agreements with vaccine producers on behalf of the EU Member States. With the Coronavirus Global Response ...

On 17 June 2020, the European Commission presented a strategy to accelerate the development, manufacturing and deployment of vaccines against the coronavirus disease (Covid-19). The strategy aims to secure high quality, safe, effective and affordable Covid-19 vaccines for all in the EU within 12-18 months, if not earlier. To this end, the Commission has started to enter into advance purchase agreements with vaccine producers on behalf of the EU Member States. With the Coronavirus Global Response initiative and its participation in the COVAX facility, the EU is also positioning itself as a leader of global solidarity effort to speed up universal access to vaccines.

Strengthening Europe in the fight against cancer

15-06-2020

This study provides an overview of the current state-of-play in Europe in respect to the fight against cancer. It focuses in particular on four main areas: causation of cancer; cancer screening and early diagnosis; access to cancer treatment, care and research; and rare and childhood cancers. It provides key findings and recommendations in each of these areas. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the committee ...

This study provides an overview of the current state-of-play in Europe in respect to the fight against cancer. It focuses in particular on four main areas: causation of cancer; cancer screening and early diagnosis; access to cancer treatment, care and research; and rare and childhood cancers. It provides key findings and recommendations in each of these areas. This document was provided by the Policy Department for Economic, Scientific and Quality of Life Policies at the request of the committee on the Environment, Public Health and Food Safety (ENVI).

Autor extern

Norbert COUESPEL et al.

COVID-19: List of the measures taken in relation to the ITRE remit - March-April 2020

12-05-2020

This briefing summarises the recent measures taken by the European Commission on matters within the remit of the Committee on Industry, Research and Energy in response to the urgent and ongoing COVID-19 crisis, while referencing relevant parts of the resolution of the European Parliament of 17 April 2020 on EU coordinated action to combat the COVID-19 pandemic and its consequences.

This briefing summarises the recent measures taken by the European Commission on matters within the remit of the Committee on Industry, Research and Energy in response to the urgent and ongoing COVID-19 crisis, while referencing relevant parts of the resolution of the European Parliament of 17 April 2020 on EU coordinated action to combat the COVID-19 pandemic and its consequences.

EU research and innovation programmes in the fight against coronavirus

08-05-2020

As part of the common European response to the coronavirus outbreak, the European Commission has mobilised €1 billion under Horizon 2020, and launched several special actions to tackle the coronavirus pandemic in Europe and abroad. These actions address, inter alia, the development of diagnostics, treatments and vaccines, and the enhancement of infrastructures and resources that enable research. The European Research Area’s action plan prioritises mainly better cooperation, data-sharing, and funding ...

As part of the common European response to the coronavirus outbreak, the European Commission has mobilised €1 billion under Horizon 2020, and launched several special actions to tackle the coronavirus pandemic in Europe and abroad. These actions address, inter alia, the development of diagnostics, treatments and vaccines, and the enhancement of infrastructures and resources that enable research. The European Research Area’s action plan prioritises mainly better cooperation, data-sharing, and funding efforts.

Amendment of the 2014-2020 MFF regulation: Using the global margin for commitments to finance measures in the healthcare sector under the Emergency Support Instrument

15-04-2020

On 2 April 2020, as part of the EU response to the needs resulting from the coronavirus outbreak, the European Commission proposed to activate the Emergency Support Instrument and reinforce the Union Civil Protection Mechanism (rescEU). Provision of funding for these measures (€3 billion) requires mobilisation of flexibility and last resort mechanisms available under the 2014-2020 Multiannual Financial Framework (MFF). In order to use the global margin for commitments for this purpose, the Commission ...

On 2 April 2020, as part of the EU response to the needs resulting from the coronavirus outbreak, the European Commission proposed to activate the Emergency Support Instrument and reinforce the Union Civil Protection Mechanism (rescEU). Provision of funding for these measures (€3 billion) requires mobilisation of flexibility and last resort mechanisms available under the 2014-2020 Multiannual Financial Framework (MFF). In order to use the global margin for commitments for this purpose, the Commission proposes to amend the provisions of the MFF Regulation and lift the restrictions on the scope of application of this flexibility mechanism. Consent from the European Parliament for this urgent request is expected to be voted during the 16-17 April plenary session.

Global and regional governance: Initial response to the COVID-19 pandemic

01-04-2020

On 11 March 2020, the World Health Organization declared the spread of COVID-19 to be a pandemic, confirming the global impact of the disease. Across the world, regional and global international organisations are stepping up coordination to confront the medical crisis and mitigate its effects on economies, societies and individuals.

On 11 March 2020, the World Health Organization declared the spread of COVID-19 to be a pandemic, confirming the global impact of the disease. Across the world, regional and global international organisations are stepping up coordination to confront the medical crisis and mitigate its effects on economies, societies and individuals.

Outcome of European Council video-conference of 26 March 2020

30-03-2020

On 26 March, EU Heads of State or Government continued their joint coordination efforts to address the COVID-19 outbreak and held a six hour long video conference on this subject, but failed to agree on the adequate financing instruments to help countries in fiscal difficulty due to the crisis, The President of the European Parliament President, David Sassoli, strongly criticised the results of the European Council and ‘the short-sightedness and selfishness of some governments’.EU leaders asked the ...

On 26 March, EU Heads of State or Government continued their joint coordination efforts to address the COVID-19 outbreak and held a six hour long video conference on this subject, but failed to agree on the adequate financing instruments to help countries in fiscal difficulty due to the crisis, The President of the European Parliament President, David Sassoli, strongly criticised the results of the European Council and ‘the short-sightedness and selfishness of some governments’.EU leaders asked the President of the Commission and the President of the European Council to start working on a Roadmap accompanied by an Action Plan to prepare an exit strategy and a comprehensive recovery plan, including unprecedented investment.

Outcome of the video-conference call of EU Heads of State or Government on 17 March 2020

23-03-2020

On 17 March, the members of the European Council held a video-conference concerning the measures taken to fight the COVID-19 outbreak. European leaders felt the need for a coordinated approach, as individual They followed up on the four lines of action to contain the spread of the disease agreed at their video-meeting on 10 March, and discussed more in depth the EU’s external and internal border management.

On 17 March, the members of the European Council held a video-conference concerning the measures taken to fight the COVID-19 outbreak. European leaders felt the need for a coordinated approach, as individual They followed up on the four lines of action to contain the spread of the disease agreed at their video-meeting on 10 March, and discussed more in depth the EU’s external and internal border management.

Outcome of the video-conference call of EU Heads of State or Government on10 March 2020

13-03-2020

Given the unprecedented circumstances surrounding the COVID-19 outbreak and the potential EU-wide ramifications, Heads of State or Government of the 27 EU Member States welcomed the initiative to hold a special meeting by video-conference on 10 March 2020. European Council President Charles Michel expressed his sympathy for all those citizens affected by the disease and, in particular, for Italy, the country most affected so far. The Member States discussed the COVID-19 outbreak and agreed on four ...

Given the unprecedented circumstances surrounding the COVID-19 outbreak and the potential EU-wide ramifications, Heads of State or Government of the 27 EU Member States welcomed the initiative to hold a special meeting by video-conference on 10 March 2020. European Council President Charles Michel expressed his sympathy for all those citizens affected by the disease and, in particular, for Italy, the country most affected so far. The Member States discussed the COVID-19 outbreak and agreed on four lines of action to contain the spread of the disease. The President of the European Commission, Ursula von der Leyen, the President of the European Central Bank, Christine Lagarde, the President of the Eurogroup, Mario Centeno, and the High Representative of the Union for Foreign Affairs and Security Policy/Vice-President of the European Commission, Josep Borrell, also took part in the discussion.

Mobile phones and health: Where do we stand?

20-03-2019

Mobile phones are an integral part of everyday life, and it is hard to imagine a world without them. There are nevertheless health concerns, and the debate is ongoing. There is a vast body of research on the potential risks from exposure to radiofrequency electromagnetic fields such as those emitted by mobile phones. Yet scientific opinion remains split over the possibility of a link between mobile phone radiation and health problems. The results of research in this area have been interpreted in ...

Mobile phones are an integral part of everyday life, and it is hard to imagine a world without them. There are nevertheless health concerns, and the debate is ongoing. There is a vast body of research on the potential risks from exposure to radiofrequency electromagnetic fields such as those emitted by mobile phones. Yet scientific opinion remains split over the possibility of a link between mobile phone radiation and health problems. The results of research in this area have been interpreted in a variety of ways, and studies have been criticised for their methodological flaws, lack of statistical significance, and bias. In 2011, the International Agency for Research on Cancer, a branch of the World Health Organization, classified radiofrequency electromagnet fields as possibly carcinogenic (cancer-causing) to humans. The European Union defined basic restrictions for limiting exposure to electromagnetic fields in Council Recommendation 1999/519/EC, setting maximum values that should not to be exceeded. Moreover, in view of the scientific uncertainty, the European Environment Agency advises taking a precautionary approach. Two sets of large-scale experimental studies involving laboratory animals, one from the United States National Toxicology Program and another from the Italian Ramazzini Institute, have recently brought the debate to the fore again. Both found varying levels of evidence of certain tumours in some of the animals tested. The results have nevertheless prompted diverging conclusions.

Evenimente viitoare

15-03-2021
EPRS online Book Talk with Vivien Schmidt: Legitimacy and power in the EU
Alt eveniment -
EPRS
16-03-2021
EPRS online policy roundtable: New European Bauhaus
Alt eveniment -
EPRS
17-03-2021
Trade related aspects and implications of COVID-19
Audiere -
INTA

Parteneri